| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |